• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » addiction

Articles Tagged with ''addiction''

Does Adolescent Vaping Lead to Cigarette Smoking?

March 1, 2018
Rehan Aziz, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Rehan Aziz, MD Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Considering them less lethal than traditional cigarettes, many adolescents are turning to electronic cigarettes as a “safer” alternative to tobacco products.
Read More

Does Moderate Alcohol Use Lead to Cognitive Decline?

March 1, 2018
Thomas Jordan, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Thomas Jordan, MD Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
It’s well established that long-term, heavy alcohol use can damage the brain and can cause problems such as Wernicke-Korsakoff syndrome and alcohol-related dementia. But what about the vast majority of our patients, who drink moderately?
Read More

New Study Shows That Vivitrol Is Just as Effective as Suboxone…But Not Really

January 1, 2018
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
A recent study in The Lancet appears to conclude that Vivitrol (extended release naltrexone) and Suboxone (buprenorphine/naloxone) are equally effective treatments for patients with opioid use disorders (Lee JD et al, The Lancet 2018;391(10118):309–318)—at least this is how the study has generally been reported.
Read More
Stigma sm

Helping Patients With Stigma and Addiction

January 1, 2018
John F. Kelly, PhD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
John F. Kelly, PhDJohn F. Kelly, PhD Dr. Kelly is the Elizabeth R. Spallin Associate Professor of Psychiatry in Addiction Medicine, Harvard Medical School. He is also founder and director of the Recovery Research Institute, Massachusetts General Hospital. Dr. Kelly has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Stigma is a condition that can be socially discrediting. When it comes to substance use disorders, internalized stigma can lead to feelings of shame. Often, people who suffer from addiction feel discriminated against. People also feel very bad about their behavior, and over time they get more disillusioned with themselves and their own ability to change.
Read More

Prescribing Gabapentin for Substance Use Disorders

January 1, 2018
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Gabapentin (Neurontin) is a “novel anticonvulsant” and is FDA indicated for partial seizures and post-herpetic neuralgia. But the drug has long been heavily marketed to psychiatrists to treat a range of conditions from bipolar disorder to anxiety to alcohol withdrawal
Read More

Interventions for Treatment or Prevention of Alcohol Hangover: Systematic Review

January 1, 2018
Adam Strassberg, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Adam Strassberg, MD Dr. Strassberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
As clinicians, we’re more interested in preventing excessive drinking than curing hangovers. But it’s always nice to have some helpful advice for patients, which we found in a recently published literature review of clinical trials of hangover treatments.
Read More

Neurostimulation for Opioid Withdrawal Symptoms

January 1, 2018
Rehan Aziz, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Rehan Aziz, MD Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
A challenging barrier for patients with opi­oid use disorders is the discomfort that can occur during the “induction phase” of their treatment, which is the period between discontinuation of opioids and initiation of medication-assisted therapy (MAT).
Read More

Substance Use in Pregnancy: What to Tell Patients

November 1, 2017
Cresta Wedel Jones, MD, FACOG
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Cresta Wedel Jones, MD, FACOG Maternal-fetal medicine physician and assistant professor at the University of Minnesota Medical School. Dr. Jones has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
In this article, I’ll start by briefly outlining what the research tells us about the risks of substance use to the fetus. The more informed you are about these risks, the more persuasive and helpful you can be to patients. I’ll then move on to discussing how, as an OB/GYN, I approach the evaluation and treatment of these patients, emphasizing issues of interest to clinicians.
Read More

Pregnancy and Substance Use Disorders

November 1, 2017
Carl Christensen, MD, PhD 
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Carl Christensen, MD, PhD  Principal, Christensen Recovery Services, Ann Arbor, MI. Dr. Christensen has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Typically, the most frequent problem that I’m referred is the pregnant patient who’s dependent on opioids. And this could be either someone who’s using illicit drugs, such as heroin, or is prescribed prescription opioids.
Read More

Can Just 11 Minutes of Mindfulness Training Reduce Alcohol Consumption?

November 1, 2017
Kirsten Pickard, BA.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Kirsten Pickard, BA. Ms. Pickard has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Mindfulness is a growing trend in mental health treatment, but it often requires hours of practice to become proficient. What if you could provide your patients with an introductory mindfulness lesson in less than 15 minutes and see meaningful reductions in their risky drinking?
Read More
Previous 1 2 … 7 8 9 10 11 12 13 14 15 … 22 23 Next
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • RogerSolomon2023.jpg
    General Psychiatry

    EMDR in Practice: A Clinician's Guide to Trauma Reprocessing with Roger Solomon, PhD

    Dr. Roger Solomon provides a comprehensive introduction to Eye Movement Desensitization and Reprocessing (EMDR).

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.